Evidence that venlafaxine does not inhibit CYP1A2 as measured in vivo by the metabolism of caffeine

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 2, 1997, Pages 179-

  Amchin, J ^a   Zarycranski, W ^a   Taylor, K ^a  

^a Wyeth Ayerst Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000445716     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)